Alexis LaChapelle

From OpenWetWare

Revision as of 17:02, 20 March 2008 by Alexis (Talk | contribs)
Jump to: navigation, search

Alexis LaChapelle, B.A.

Research Assistant II


Alexis graduated in 2005 from Willamette University with a BA in Biology and is currently doing general lab work for the Hoatlin lab. Her hobbies include doing origami, stair surfing, hiding at the back of step aerobics class, and rockin' the suburbs. If not in the lab, Alexis can often be found in the ER.

Email: lachapel AT ohsu DOT edu

Publications

  • LaChapelle, A. M., Ruygrok, M. L., Toomer, ME., Oost, J. J., Monnie, M. L., Swenson, J. A., Compton, A. A., Stebbins-Boaz-, B. 2006. The hormonal herbicide, 2,4-dichlorophenoxyacetic acid, inhibits Xenopus oocyte maturation by targeting translational and post-translational mechanisms. Reprod. Toxicol. 2007 Jan;23(1):20-31.
  • Stebbins-Boaz, B., Compton, A., LaChapelle, A., Monnie, M., Oost, J., Ruygrok, M., Swenson, J. 2005. The hormonal herbicide, 2,4-D, induces a signaling response in Xenopus oocytes that interferes with meiotic maturation in vitro. Mol. Biol. Cell 16S:741a.

Abstracts

  • 2006 IMMUNOISOLATION AND PARTIAL CHARACTERIZATION OF FANCONI ANEMIA PROTEIN COMPLEXES IN XENOPUS EGG EXTRACTS. S.Stone, A.Sobeck, A.LaChapelle, H.Joenje, W.Wang, M.E.Hoatlin. 18th Annual Fanconi Anemia Research Fund Scientific Symposium Bethesda, MD.
  • 2006 SEQUENTIAL RECRUITMENT OF FANCONI ANEMIA PROTEINS TO REPLICATING CHROMATIN. A.Sobeck, S.Stone, A.LaChapelle, M.E.Hoatlin. (Platform presentation) 11th Annual Xenopus Conference, Chiba, Japan.
  • 2006 A CELL-FREE ASSAY TO SCREEN FOR COMPOUNDS THAT MODULATE THE FANCONI/BRCA PATHWAY. (Poster) Stacie Stone, Alexandra Sobeck, Igor Landais, Alexis LaChapelle, and Maureen E. Hoatlin. 48th Annual Hematology Society Meeting. Orlando, FL.
  • 2006 A CELL-FREE ASSAY TO SCREEN FOR COMPOUNDS THAT MODULATE THE FANCONI/BRCA PATHWAY (Poster). Igor Landais, Stacie Stone, Alexandra Sobeck,, Alexis LaChapelle, and Maureen E. Hoatlin. 18th Annual Fanconi Anemia Research Fund Scientific Symposium, Bethesda, MD.
  • 2006 A XENOPUS CELL-FREE ASSAY FOR SCREENING OF COMPOUNDS THAT MODULATE THE FANCONI ANEMIA PATHWAY (Poster). Igor Landais, Alexandra Sobeck, Stacie Stone, Alexis LaChapelle, and Maureen E. Hoatlin. 18th Annual Fanconi Anemia Research Fund Scientific Symposium, Bethesda, MD.
  • 2007 A NOVEL CELL-FREE SCREEN FOR DRUGS THAT MODULATE THE HUMAN FANCONI/BREAST CANCER SUSCEPTIBILITY PROTEIN NETWORK (Poster, Eli Lilly-AACR Scholar-in-training award). Landais I, Sobeck A, Stone S, LaChapelle A, Hoatlin ME. AACR-NCI-EORTC International Conference, Molecular Targets and Cancer Therapeutics. San Francisco, CA.
  • 2007 DIFFERENTIAL ACTIVATION OF CORE COMPLEX MEMBER FANCM AND DOWNSTREAM TARGET FANCD2 (Oral presentation by Postdoctoral Fellow, A. Sobeck). Sobeck A, Stone S, LaChapelle A, Landais I, Hoatlin ME. 19th Annual Fanconi Anemia Research Fund Scientific Symposium, Chicago, IL.
  • 2007 IDENTIFICATION OF A NOVEL PARTNER FOR FANCM (Oral presentation by Graduate Student, S. Stone). Stone S, Sobeck A, LaChapelle A, Landais I, W. Wang, Hoatlin ME. 19th Annual Fanconi Anemia Research Fund Scientific Symposium, Chicago, IL.


Back to Main Page Hoatlin Lab

Personal tools